Examining Antimicrobial Stewardship Program Implementation in Carceral Settings
- PMID: 38700524
- PMCID: PMC12001836
- DOI: 10.1001/amajethics.2024.399
Examining Antimicrobial Stewardship Program Implementation in Carceral Settings
Abstract
Antimicrobial resistance is a global threat that inequitably affects minoritized populations, including Black, Latinx, and Indigenous people-especially in carceral settings-and is largely driven by inappropriate antimicrobial prescribing practices. People whose identities are minoritized are more likely to be incarcerated, and people who are incarcerated experience higher disease risk than people who are not incarcerated. This article draws on a case of dental infection suffered by a woman who is incarcerated to consider key ethical and clinical complexities of antimicrobial prescribing in carceral settings.
Copyright 2024 American Medical Association. All Rights Reserved.
Conflict of interest statement
Conflict of Interest Disclosure
Dr Abdul-Mutakabbir has served on advisory boards and received honoraria from Shionogi, Entasis Therapeutics, CSL Sequiris, Innoviva Specialty Therapeutics, and Abbvie; she also reports serving as an appointed member of the CVS Health National Health Equity Advisory Board. The other authors disclosed no conflicts of interest.
Figures
References
-
- National infection and death estimates for antimicrobial resistance. Centers for Disease Control and Prevention. Reviewed December 13, 2021. Accessed October 5, 2023. https://www.cdc.gov/drugresistance/national-estimates.html
-
- Bick JA. Infection control in jails and prisons. Clin Infect Dis. 2007;45(8):1047–1055. - PubMed
-
- Barrett FF, McGehee RF Jr, Finland M. Methicillin-resistant Staphylococcus aureus at Boston City Hospital: bacteriologic and epidemiologic observations. N Engl J Med. 1968;279(9):441–448. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources